Clinical features of bacterial meningitis in Italy: A multicenter prospective observational study

Journal of Chemotherapy

Volumn 20, Issue 4, 2008, Pages 478-487

  Lazzarini, L ^a   Toti, M ^b,e   Fabris, P ^a   Conti, E ^a   Magni, G ^c   Mazzotta, F ^d   De Lalla, F ^a   Acone, N ^e   Dell'Aquila, G ^e   Pastore, G ^e   Buongiorno, R ^e   Francavilla, E ^e   Granata, C ^e   Maio, G ^e   Sangiuolo, A ^e   Andreoni, M ^e   Bellissima, P ^e   Russo, R ^e   Tosto, S ^e   Stagno, A ^e   Beltrami, C ^e   Brighi, S ^e   Guaglianone, L ^e   Luciani, F ^e   Carnevale, G ^e   Vigano P ^e   Re, T ^e   Fiore, M ^e   Ciao, V ^e   Padovani, P ^e   Ghinelli, F ^e   Bicocchi, R ^e   Leoncini, F ^e   Pozzi, M ^e   Angarano, G ^e   Scotto, G ^e   Palumbo, E ^e   Cancellieri, C ^e   Pagano, G ^f   Camera, M ^f   Cassola, G ^g   Giomi, S ^e   Iannessi, A ^e   Cellini, A ^e   Soscia, F ^e   Salone, G ^e   Rovere, P ^e   Scasso, A ^e   Chiodera, A ^e   Todaro, G ^e   Orifici, G ^e   Moroni, M ^h   Negri, C ^h   Cargnel, A ^h   Gubertini, G ^h   Bisoffi, Z ^e   Marocco, S ^e   Sapienza, M ^e   Benenati, P ^e   Colucci, M ^e   Giordano, G ^e   Baldelli, F ^e   Di Candilo, F ^e   Alberici, F ^e   Ratti, G ^e   Zauli, T ^e   Foti, G ^e   Magnani, G ^e   Rossi, G ^e   Arlotti, M ^e   Ortolani, P ^e   Petrosillo, N ⁱ   Renda, V ^j   Iaiani, G ^j   Narciso, P ⁱ   Ghirga, P ⁱ   Paffetti, A ^j   Mannozzi, P ^j   Vullo, V ^j   Massetti, A P ^j   Carretta, M ^e   Viviani, F ^e   Frongillo, R F ^e   Palumbo, M ^e   Caramello, P ^e   Gaiottino, F ^e   Viale, P ^e   Crapis, M ^e   Grossi, P ^e   Dinatale, ^e   Poggio, A ^e   Mondino, V ^e   more..

^a SAN BORTOLO HOSPITAL   (Italy)

^b MISERICORDIA HOSPITAL   (Italy)

^c QBGroup SpA   (Italy)

^d President of Societa Italiana di Malattie Infettive e Tropicali (SIMIT)   (Italy)

^e O San Martino ^*

^f UNIVERSITY OF GENOA   (Italy)

^g GALLIERA HOSPITAL   (Italy)

^h II Div Mal Infettive   (Italy)

ⁱ NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^j POLICLINICO UMBERTO I   (Italy)

more..

Author keywords

Ampicillin; Ceftriaxone; Italy; Meningitis; Steroids

Indexed keywords

AMPICILLIN; ANTIBIOTIC AGENT; CEFOTAXIME; CEFTRIAXONE; CHLORAMPHENICOL; CORTICOSTEROID; LEVOFLOXACIN; LINEZOLID; MEROPENEM; PENICILLIN G; RIFAMPICIN; STEROID; VANCOMYCIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL MENINGITIS; BACTERIUM CULTURE; CEREBROSPINAL FLUID CULTURE; CLINICAL FEATURE; COMA; CONTROLLED STUDY; FEVER; HUMAN; ITALY; LENGTH OF STAY; MAJOR CLINICAL STUDY; MONOTHERAPY; MORTALITY; NEISSERIA MENINGITIDIS; NEUROLOGIC DISEASE; NONHUMAN; OBSERVATIONAL STUDY; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; STREPTOCOCCUS PNEUMONIAE;

EID: 52349084409     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.2008.20.4.478     Document Type: Article

References (23)

1. Tunkel AR, Scheld WM. Acute Meningitis. In: Mandell GL, Bennett JE, Dolin R. Principles and practice of infectious diseases. Philadelphia, PA, 2000; 959-997.
2. Schuchat A, Robinson K, Wenger JD, Harrison LH, Farley M, Reingold AL, Lefkowitz L, Perkins BA. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med 1997; 337: 970-6.
3. Sigurdardottir B, Bjornsson OM, Jonsdottir KE, Erlendsottir H, Gundmundsson S. Acute bacterial meningitis. A 20-year overview. Arch Intern Med 1997; 157: 425-30.
4. Durand ML, Calderwood SB, Weber DJ, Miller SI, Southwick FS, Caviness VS Jr, Swartz MN. Acute bacterial meningitis in adults. A review of 493 episodes. N Engl J Med 1993; 328: 21-8.
5. Van de Beek D, de Gans J, Tunkel AR, Wijdicks EFM. Community acquired meningitis in adults. N Engl J Med 2006; 354: 44-53.
6. Faustini A, Arcà M, Fusco D, Perucci CA. Prognostic factors and determinants of fatal outcome due to bacterial meningitis in the Lazio region of Italy. Int J Infect Dis 2007; 11: 137-44.
7. Marchese A, Ardito F, Fadda G, Fontana R, Lo Cascio G, Nicoletti G, et al. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumonite and Haemophilus spp. In Italy. Int J Antimicrob Agents 2005; 26: 8-12.
8. Reinert RR, Reinert S, van der Linden M, Cil MY, Al-Lahham A, Appelbaum P. Antimicrobial susceptibility of Streptococcus pneumoniae in eight European countries from 2001 to 2003. Antimicrob Agents Chemother 2005; 49 (7): 2903-13.
9. Dodge PR, Swartz MN. Bacterial meningitis- a review of selected aspects. II. Special neurologic problems, postmeningitic complications and clinicopathological correlations. N Engl J Med 1965; 272: 954-60.
10. Pfister HW, Feiden W, Einhauol KM. Spectrum of complications during bacterial meningitis in adults: results of a prospective clinical study. Arch Neurol 1993; 50: 575-81.
11. Weststrate W, Hijdra A, de Gans J. Brain infarcts in adults with bacterial meningitis. Lancet 1996; 347: 399.
12. Kastenbauer S, Pfister HW. Pneumococcal meningitis in adults - spectrum of complications and prognostic factors in a series of 87 cases. Brain 2003; 126: 1015-25.
13. Auburtin M, Wolff M, Charpentier J, Varon E, Le Tulzo Y, Girault C, et al. Detrimental role of delayed antibiotic administration and penicillin-non susceptible strains in adult intensive care unit patients with pneumococcal meningitis: the PNEU-MOREA prospective multicenter study. Crit Care Med 2006; 34: 2758-65.
14. Aronin SI, Peduzzi P, Quagliarello VJ. Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing. Ann Intern Med 1998; 129: 862-9.
15. de Lalla F, Nicolin R, Lazzarini L. Safety and efficacy of recombinant granulocyte colony-stimulating factor as an adjunctive therapy for Streptococcus pneumoniae meningitis in non-neutropenic adult patients: a pilot study. J Antimicrob Chemother. 2000;46:843-6.
16. Syrogiannopoulos GA, Lourida AN, Theodoridou MC, Pappas IG, Babilis GC, Economidis JJ, et al. Dexamethasone therapy for bacterial meningitis in children: 2- versus 4-day regimen. J Infect Dis 1994; 169: 853-8.
17. Weisfelt M, van de Beek D, de Gans J. Dexamethasone treatment in adults with pneumococcal meningitis: risk factors for death. Eur J Clin Microbiol Infect Dis 2006; 25: 73-8.
18. Johnston JR. Delayed Treatment of bacterial meningitis. Ann Intern Med 1999; 131: 715.
19. McIntyre PB, Berkey CS, King SM, Schaad UB, Kilpi T, Kanra GY, et al. Dexamethasone as adjunctive therapy in bacterial meningitis. A meta-analysis of randomized clinical trials since 1988. JAMA. 1997; 278: 925-31.
20. van de Beek D, de Gans J, McIntyre P, Prasad K. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2007;(1):CD004405.
21. Korshin A, Køter-Rasmussen R, Meyer CN, Group FT. Adjunctive steroid treatment: Local guidelines and patient outcome in adult bacterial meningitis. Scand J Infect Dis. 2007; 39 (11-12): 963-8.
22. Nguyen TH, Tran TH, Thwaites G, Ly VC, Dinh XS, Ho Dang TN, et al. Dexamethasone in Vietnamese adolescents and adults with bacterial meningitis. N Engl J Med. 2007; 357(24): 2507-9.
23. Scarborough M, Gordon SB, Whitty CJ, French N, Njalale Y, Chitani A, et al. Corticosteroids for bacterial meningitis in adults in sub-Saharan Africa. N Engl J Med. 2007; 357(24): 2507-9.